AG
ELOX

Advisor Group’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Advisor Group’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$91K Hold
309
– – ﹤0.01% 3011
2019
Q3 		$56K Hold
309
– – ﹤0.01% 3317
2019
Q2 		$123K Buy
309
+254
+462% +$107K ﹤0.01% 2701
2019
Q1 		$26K Hold
55
– – ﹤0.01% 3843
2018
Q4 		$27K Hold
55
– – ﹤0.01% 3625
2018
Q3 		$38K Sell
55
-90
-62% -$57.6K ﹤0.01% 3488
2018
Q2 		$99K Buy
+145
New +$94K ﹤0.01% 2531

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Advisor Group's ELOX Position: Q4 2019 in Review

Advisor Group held its Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) position steady in Q4 2019 at 309 shares worth $91K. The position accounts for ﹤0.01% of the portfolio, ranked #3011.

Advisor Group first reported a position in ELOX in Q2 2018 and has held it in 7 quarters since. The position peaked at $123K in Q2 2019. 46 funds tracked by Wall St. Rank hold ELOX as of Q4 2019.

  • Advisor Group held 309 shares of Eloxx Pharmaceuticals, Inc. Common Stock worth $91K as of Q4 2019.
  • Advisor Group left its Eloxx Pharmaceuticals, Inc. Common Stock share count unchanged in Q4 2019.
  • Eloxx Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3011 holding.
  • Advisor Group first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and has held it in 7 quarters since.
  • Advisor Group's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $123K in Q2 2019.
  • 46 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.